Literature DB >> 25476740

CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.

Zhenyu Zhu1, Xukui Zhang, Hongliang Guo, Ling Fu, Ganlin Pan, Yinggang Sun.   

Abstract

CXCL13, an inflammatory factor in the microenvironment, plays a vital role in the progression of inflammatory diseases and tumors. CXCL13 and its receptor CXCR5 have been reported to be associated with poor prognosis of advanced colon cancer. However, the molecular mechanisms of CXCL13-CXCR5 axis in colon cancer remain elusive. The aim of this study was to investigate the role of CXCR5-CXCL13 axis in the growth and invasion of colon cancer cells. Our results showed that CXCL13 promoted the growth, migration, and matrigel invasion of colon cancer cells. Furthermore, CXCL13 increased the expression and secretion of MMP-13, and stimulated the activation of PI3K/AKT pathway. After knockdown of CXCR5 by siRNA, the biological functions of colon cancer cells regulated by CXCL13 were significantly inhibited. In addition, inhibition of PI3K/AKT pathway by specific inhibitor LY294002 suppressed the CXCL13-mediated growth, migration, and invasion of colon cancer cells. Together, our findings suggest that CXCL13-CXCR5 axis promotes the growth, migration, and invasion of colon cancer cells, probably via PI3K/AKT pathway. Thus, CXCL13 may be a useful biomarker for the detection and treatment of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25476740     DOI: 10.1007/s11010-014-2285-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

Review 1.  G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts.

Authors:  Claus Liebmann
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Role of CXCL13 in asthma: novel therapeutic target.

Authors:  Guillermina Juliana Baay-Guzman; Sara Huerta-Yepez; Mario I Vega; Diana Aguilar-Leon; Monica Campillos; Jonathon Blake; Vladimir Benes; Rogelio Hernandez-Pando; Luis M Teran
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

3.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

4.  Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

Authors:  Evangelia Razis; Konstantine T Kalogeras; Vassiliki Kotoula; Anastasia G Eleftheraki; Nikitas Nikitas; Ralf Kronenwett; Eleni Timotheadou; Christos Christodoulou; Dimitrios Pectasides; Helen Gogas; Ralph M Wirtz; Thomas Makatsoris; Dimitrios Bafaloukos; Gerasimos Aravantinos; Despina Televantou; Nicholas Pavlidis; George Fountzilas
Journal:  Clin Breast Cancer       Date:  2012-06       Impact factor: 3.225

Review 5.  Matrix metalloproteinase inhibitors in the treatment of cancer.

Authors:  P D Brown
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 6.  Role of matrix metalloproteinases (MMPs) in colorectal cancer.

Authors:  Stanley Zucker; Jeffrey Vacirca
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

Review 7.  Cell survival and metastasis regulation by Akt signaling in colorectal cancer.

Authors:  Ekta Agarwal; Michael G Brattain; Sanjib Chowdhury
Journal:  Cell Signal       Date:  2013-04-18       Impact factor: 4.315

Review 8.  Evolving treatment of advanced colon cancer.

Authors:  Neil H Segal; Leonard B Saltz
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

9.  Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.

Authors:  Subramanya N M Pandruvada; Sambandam Yuvaraj; Xiang Liu; Kumaran Sundaram; Srinivasan Shanmugarajan; William L Ries; James S Norris; Steven D London; Sakamuri V Reddy
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

10.  Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.

Authors:  J Panse; K Friedrichs; A Marx; Y Hildebrandt; T Luetkens; K Barrels; C Horn; T Stahl; Y Cao; K Milde-Langosch; A Niendorf; N Kröger; S Wenzel; R Leuwer; C Bokemeyer; S Hegewisch-Becker; D Atanackovic
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  45 in total

1.  Signaling via the CXCR5/ERK pathway is mediated by CXCL13 in mice with breast cancer.

Authors:  Licheng Xu; Zhi Liang; Shuyan Li; Jianjun Ma
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

2.  CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.

Authors:  Judith N Wagner; S Weis; C Kubasta; J Panholzer; T J von Oertzen
Journal:  J Neurol       Date:  2017-11-13       Impact factor: 4.849

3.  Neuroprotective effect of miR-410-3p against sevoflurane anesthesia-induced cognitive dysfunction in rats through PI3K/Akt signaling pathway via targeting C-X-C motif chemokine receptor 5.

Authors:  Rui Su; Ping Sun; Dianhong Zhang; Wei Xiao; Chun Feng; Liang Zhong
Journal:  Genes Genomics       Date:  2019-07-26       Impact factor: 1.839

Review 4.  Mechanisms of cancer dissemination along nerves.

Authors:  Moran Amit; Shorook Na'ara; Ziv Gil
Journal:  Nat Rev Cancer       Date:  2016-05-06       Impact factor: 60.716

5.  Identification and Interaction Analysis of Key Genes and MicroRNAs in Systemic Sclerosis by Bioinformatics Approaches.

Authors:  Yan-Hong Sun; Meng Xie; Shi-di Wu; Jing Zhang; Chang-Zheng Huang
Journal:  Curr Med Sci       Date:  2019-07-25

6.  Distribution of circulating follicular helper T cells and expression of interleukin-21 and chemokine C-X-C ligand 13 in gastric cancer.

Authors:  Xinying Meng; Xinjuan Yu; Quanjiang Dong; Xiaona Xu; Jinghua Li; Qianqian Xu; Jian Ma; Changhong Zhou
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

Review 7.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

8.  CXCL13 Signaling in the Tumor Microenvironment.

Authors:  Muzammal Hussain; Jinsong Liu; Gui-Zhen Wang; Guang-Biao Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Cancer Conditioned Medium Modulates Functional and Phenotypic Properties of Human Decidua Parietalis Mesenchymal Stem/Stromal Cells.

Authors:  E Bahattab; T Khatlani; F M Abomaray; S A Messaoudi; M H Abumaree
Journal:  Tissue Eng Regen Med       Date:  2019-11-01       Impact factor: 4.169

10.  A nine-gene signature to improve prognosis prediction of colon carcinoma.

Authors:  Jinlai Zhao; Yigang Wang; Jianchao Gao; Yang Wang; Xuan Zhong; Xiaotang Wu; Hua Li
Journal:  Cell Cycle       Date:  2021-05-14       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.